Skip to NavigationSkip to content

Reuters chief executive joins Pfizer board

Published on: 02/07/14

Pfizer has appointed the chief executive of information and media giant Thomson Reuters to its board of directors.

James Smith joins the firm immediately and has also been appointed to its corporate governance and science and technology committee.

Smith is the president and chief executive of Thomson Reuters where he has served on its board of directors since January 2012. Prior to this he held various leadership positions there, including chief executive and chief operating officer (COO) of its professional division.

Pfizer chairman and chief executive Ian Read, says: “We are pleased to have Jim Smith join Pfizer’s board of directors. He brings leadership and operational and international business experience to Pfizer’s Board, and will be an excellent asset to the company.”

Prior to the acquisition of Reuters by Thomson, he served as COO of Thomson and president and chief executive of its learning’s academic and reference group.

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches